STAAR Surgical To Present At Upcoming Investor Conferences

          STAAR Surgical To Present At Upcoming Investor Conferences

PR Newswire

MONROVIA, Calif., May 21, 2013

MONROVIA, Calif., May 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ:
STAA), a leading developer, manufacturer and marketer of minimally invasive
ophthalmic products, today announced that it will participate in three
upcoming investor conferences to review the Company's recent financial results
and business developments with investors and interested parties.

STAAR Surgical will present at the 38^th Annual Deutsche Bank 2013 Healthcare
Conference in Boston at the Westin Waterfront Hotel on Wednesday, May 29, 2013
at 10:40 a.m. ET. Barry G. Caldwell, President and CEO and Hans
Blickensdoerfer, President, Europe, Middle East, Africa, will be presenting at
the conference.

The Benchmark Company One-on-One Investor Conference will be held on Thursday,
May 30, 2013 at the Pfister Hotel in Milwaukee, Wisconsin. Barry Caldwell and
Hans Blickensdoerfer will meet with interested investors in a series of
one-on-one meetings.

The Company will also present at the Jefferies 2013 Global Healthcare
Conference at the Grand Hyatt Hotel in New York on Thursday, June 6, 2013 at
2:00 p.m. ET. Barry Caldwell and Sam Gesten, General Counsel, will be
presenting at the conference.

STAAR will offer a live video webcast of its presentations at Deutsche Bank
and Jefferies on the Company's website,, under Investor
Information. An archived replay of these presentations will be available for
90 days following the event date, also at The Benchmark
conference does not provide for companies to webcast the event.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25
years, designs, develops, manufactures and markets implantable lenses for the
eye and delivery systems therefor. All of these lenses are foldable, which
permits the surgeon to insert them through a small incision. STAAR's lens used
in refractive surgery as an alternative to LASIK is called an Implantable
CollamerĀ® Lens or "ICL." A lens used to replace the natural lens after
cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian
ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and
markets lenses in over 60 countries. Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Ichikawa City,
Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit
the Company's website at

CONTACT: Investors                   Media
         EVC Group                   EVC Group
         Douglas Sherk, 415-652-9100 Amy Phillips, 412-327-9499
         Leigh Salvo, 415-568-9348

SOURCE STAAR Surgical Company

Press spacebar to pause and continue. Press esc to stop.